Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY Begin, P., Dominguez, T., Wilson, S. P., Bacal, L., Mehrotra, A., Kausch, B., Trela, A., Tavassoli, M., Hoyte, E., O'Riordan, G., Blakemore, A., Seki, S., Hamilton, R. G., Nadeau, K. C. 2014; 10

View details for DOI 10.1186/1710-1492-10-7

View details for Web of Science ID 000332419100001